165 related articles for article (PubMed ID: 1284096)
21. Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.
Mazda T; Nakata K; Bannai M; Miyamura T; Chiba J; Ohba H; Kaminuma Y; Katayama T
Transfus Med; 1993 Jun; 3(2):149-51. PubMed ID: 7690640
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of HBsAg, anti-HCV and anti-HDV positivity in diverse groups].
Doğanay M; Patiroğlu T; Utaş C; Ozbakir O; Unal A; Utaş S; Aygen B; Yücesoy M
Mikrobiyol Bul; 1993 Apr; 27(2):107-12. PubMed ID: 7684812
[TBL] [Abstract][Full Text] [Related]
23. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors].
Cavdar E; Kuştimur S; Doğruman Al F
Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694
[TBL] [Abstract][Full Text] [Related]
24. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
25. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
Wang SP; Ding H; Zhao OK
Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
[TBL] [Abstract][Full Text] [Related]
27. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
[TBL] [Abstract][Full Text] [Related]
28. Comparative infectious serology testing of pre- and post-mortem blood samples from cornea donors.
Wilkemeyer I; Pruss A; Kalus U; Schroeter J
Cell Tissue Bank; 2012 Aug; 13(3):447-52. PubMed ID: 22802139
[TBL] [Abstract][Full Text] [Related]
29. Should the c100 antigen be removed from HCV antibody assays?
Zaaijer HL; Cuypers HT; Reesink HW; Lelie PN
Vox Sang; 1994; 66(2):150. PubMed ID: 7514326
[No Abstract] [Full Text] [Related]
30. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
31. Head-to-head comparison between two screening systems for HBsAG, anti-HBc, anti-HCV and HIV combination immunoassays in an international, multicentre evaluation study.
Schmidt M; Jimenez A; Mühlbacher A; Oota S; Blanco L; Sakuldamrongpanich T; Schennach H; Seifried E
Vox Sang; 2015 Aug; 109(2):114-21. PubMed ID: 25899479
[TBL] [Abstract][Full Text] [Related]
32. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
33. [The hepatitis C problem in transfusions in military medicine].
Danil'chenko VV; Zhiburt EB; Bel'gesov NV; Serebrianaia NB; Sidorkevich SV
Voen Med Zh; 1994 Jun; (6):44-5, 80. PubMed ID: 7941454
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
[TBL] [Abstract][Full Text] [Related]
35. Transfusion-transmitted hepatitis virus infection.
Dodd RY
Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
[TBL] [Abstract][Full Text] [Related]
36. Comparative results in detection of HCV antibodies by using a rapid HCV test, ELISA and immunoblot.
Poovorawan Y; Theamboonlers A; Chumdermpadetsuk S; Thong CP
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):647-9. PubMed ID: 7545315
[TBL] [Abstract][Full Text] [Related]
37. [Transfusion safety].
Aprili G
Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
[No Abstract] [Full Text] [Related]
38. [Analytical study of the Abbott and Ortho tests for screening and confirmation of anti-HCV antibodies. Le groupe de Travail "Hépatites virales" de la Société Française de Transfusion Sanguine].
Janot C; Couroucé AM; Boudart D; Cotte C; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M; Mattlinger B
Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):171-82. PubMed ID: 1384522
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan.
Tanaka H; Hiyama T; Tsukuma H; Okubo Y; Yamano H; Kitada A; Fujimoto I
Cancer Causes Control; 1994 Sep; 5(5):409-13. PubMed ID: 7999962
[TBL] [Abstract][Full Text] [Related]
40. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
